Literature DB >> 8338346

Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.

A Churchyard1, G A Donnan, A Hughes, D W Howells, D Woodhouse, J Y Wong, R M Kalnins, F A Mendelsohn, G Paxinos.   

Abstract

Postmortem autoradiography was used to explore the mechanisms underlying L-dopa resistance in 2 patients with multiple-system atrophy. Indices of striatal presynaptic dopamine terminal loss and dopamine (D1 and D2) receptors were provided by 3H-mazindol, 3H-SCH 23390, and 125I-sulpiride binding. Neuronal loss, gliosis, and loss of postsynaptic D2 receptors preferentially involved the middle and posterior of the putamen, that region of the striatum most intimately involved in motor function. Loss of D1 receptors in the same area occurred in only 1 patient. These findings suggest that in multiple-system atrophy, resistance to L-dopa is due to a loss of putamental D2 receptors. The differential effects on D1 and D2 receptors in 1 patient implies that different subpopulations of striatal neurons were selectively involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338346     DOI: 10.1002/ana.410340219

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Multiple system atrophy: cellular and molecular pathology.

Authors:  D J Burn; E Jaros
Journal:  Mol Pathol       Date:  2001-12

Review 3.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

4.  Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.

Authors:  M Ghaemi; R Hilker; J Rudolf; J Sobesky; W-D Heiss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

5.  The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.

Authors:  Mathias Schreckenberger; Stefan Hägele; Thomas Siessmeier; Hans-Georg Buchholz; Heike Armbrust-Henrich; Frank Rösch; Gerhard Gründer; Peter Bartenstein; Thomas Vogt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-23       Impact factor: 9.236

6.  A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.

Authors:  Hyung Ho Yoon; Yong Hwan Kim; Eun Sil Shin; Sang Ryong Jeon
Journal:  J Korean Med Sci       Date:  2014-11-04       Impact factor: 2.153

7.  Discovering the 3' UTR-mediated regulation of alpha-synuclein.

Authors:  Domenica Marchese; Teresa Botta-Orfila; Davide Cirillo; Juan Antonio Rodriguez; Carmen Maria Livi; Rubén Fernández-Santiago; Mario Ezquerra; Maria J Martí; Elias Bechara; Gian Gaetano Tartaglia
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

Review 8.  Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy.

Authors:  Nicole Campese; Alessandra Fanciulli; Nadia Stefanova; Johannes Haybaeck; Stefan Kiechl; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2021-07-28       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.